References
- Minister of Health, letter to the Cabinet: CZ/IZ-2612095; 15 September 2005
- Wapner R, Thom E, Simpson J L, Pergament E, Silver R, Filkins K, et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group. First-trimester screening for trisomies 21 and 18. New Engl J Med 2003; 349: 1405–1413
- Nicolaides K H, Spencer K, Avgidou K, Faiola S, Falcon O, et al. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221–226
- Ellestad S C, Wells S R, Kuller J A. First trimester screening. Gynecol Obstet Invest 2005; 60: 58–62
- Wilson J A, Barton D. Targeted versus whole-genome array comparative genome hybridization: the Atlantic divide. J Mol Diagn 2007; 9: 278
- Veltman J A, Schoenmakers E F, Eussen B H, Janssen I, Merkx G, van Cleef B, et al. High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparatative genomic hybridization. Am J Hum Genet 2002; 70: 1269–1276
- Veltman J A, de Vries B B. Whole-genome array comparative genome hybridisation: the preferred diagnostic choice in postnatal cytogenetics. J Mol Diagn 2007; 9: 277
- Schouten J P, McElgunn C J, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: 12 e57
- Slater H R, Bruno D L, Ren H, Pertile M, Schouten J P, Choo K H. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet 2003; 40: 907–912
- Gerdes T, Kirchhoff M, Lind A M, Larsen G V, Schwartz M, Lundsteen C. Computer-assisted prenatal aneuploidy screening for chromosome 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA). Eur J Hum Genet 2005; 13: 171–175
- Hochstenbach R, Meijer J, van de Brug J, Vossebeld-Hoff I, Jansen R, van der Luijt R B, et al. Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA). Prenat Diagn 2005; 25: 1032–1039
- ZonMw feasibility study nr 5483. “M.A.K.E.: MLPA and karyotyping, an evaluation”; multicenter study in eight University Centres of Prenatal Diagnostics in the Netherlands. 2007
- Grody W W. Ethical issues raised by genetic testing with oligonucleotide microarrays. Mol Biotechnol 2003; 23: 127–138
- Lau T K, Leung T N. Genetic screening and diagnosis. Curr Opin Obstet Gynecol 2005; 17: 161–162
- The Ethox Centre; Department of Public Health & Primary Healthcare. Medical Sciences. University of Oxford, OxfordUK 2005, Specific ethical considerations relevant to genetic issues in healthcare. In: Medical Ethics Today – the BMA's handbook of ethics and law. BMJ Publishing Group; 2004. p. 308
- Michie S, French D, Allanson A, Bobrow M, Marteau T M. Information recall in genetic counselling: a pilot study of its assessment. Patient Educ Couns 1997; 32: 93–100
- Völler H, Dovifat C, Glatz J, Körtke H, Taborski U, Wegscheider K. Self management of oral anticoagulation with the IN ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442–447
- Hoedjes M. Knowledge about prenatal screening and diagnostic tests. Department of Medical Psychology, Tilburg University. 2006, Masters' thesis
- Dormandy E, Michie S, Hooper R, Marteau T M. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices. Int J Epidemiol 2005; 34: 346–352
- Baker H, Uus K, Bamford J, Marteau T M. Increasing knowledge about a screening test: preliminary evaluation of a structured, chart-based, screener presentation. Patient Educ Couns 2004; 52: 55–59
- Van den Berg M, Timmermans D R, Ten Kate L P, van Vugt J M, van der Wal G. Are pregnant women making informed choices about prenatal screening. Genet Med 2005; 7: 332–338
- Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Kanhai H, et al. Experience in prenatal testing for Huntington's disease in the Netherlands: procedures, results and guidelines (1987–1997). Prenat Diagn 1999; 19: 450–457
- Redon R, Ishikawa S, Fitch K R, Feuk L, Perry G H, Andrews T D, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444–454